Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Direct observations: clinical cases, poisoning incidents and other

Currently viewing:

Administrative data

direct observations: clinical cases, poisoning incidents and other
Type of information:
other: dossier on the toxicological profile of CTC
Adequacy of study:
other information
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: secondary source

Data source

Reference Type:
secondary source
Toxicological profile for carbon tetrachloride
Bibliographic source:
U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry

Materials and methods

Test material

Constituent 1
Chemical structure
Reference substance name:
Carbon tetrachloride
EC Number:
EC Name:
Carbon tetrachloride
Cas Number:
Molecular formula:

Results and discussion

Applicant's summary and conclusion

Executive summary:

summary of clinical cases as described in the ATDSR dossier (August 2005):

"Ingestion of concentrated solutions of CTC can cause death in humans within hours to days. The principal clinical signs observed in fatal cases include gastrointestinal irritation, central nervous system depression, and cardiovascular disturbances, with death usually resulting from severe injury to kidney and/or liver. Effects on lungs were observed, too (edema and hemorrhage).

There is considerable variation in the doses that have been found to cause lethality.

A case of polyneuritis was reported in a man who had repeated dermal contact 8 hours/day to CTC using it as a degreasing agent. Sudden severe epileptiform seizure and coma occurred in a subsequently fatal case following weekly combined inhalation/dermal exposure. The individual was alcoholic.

Exposure levels to CTC leading to effects on the central nervous systems of humans are not precisely defined. No symptoms of light headedness or nausea were experienced by humans exposed to 50 ppm for 70 minutes or 10 ppm for 3 hours, but nausea, headache, and giddiness were found to be common symptoms in workers exposed to CTC for 8 hours/day at concentrations of 20– 125 ppm.

Dizziness has also been reported in humans following short-term exposure (15 minutes) at a higher concentration (250 ppm) (Norwood et al. 1950). This suggests that the threshold for central nervous system effects in humans is, as a conservative estimate, probably in the range of 20–50 ppm for an 8-hour workday.

Most studies of humans exposed to CTC by inhalation have not detected significant evidence of cardiovascular injury, even at exposure levels sufficient to markedly injure the liver and/or kidney."